Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 19;16(1):50.
doi: 10.1186/s13011-021-00388-5.

Tailoring services in opioid treatment programs for patients involved in America's criminal justice system: national associations and variation by state and Medicaid expansion status

George Pro  1 , Brooke E E Montgomery  2 , Nickolas Zaller  2
Affiliations

Tailoring services in opioid treatment programs for patients involved in America's criminal justice system: national associations and variation by state and Medicaid expansion status

George Pro et al. Subst Abuse Treat Prev Policy. .

Abstract

Background: Opioid treatment programs (OTPs) are the primary source of medication-assisted treatment (MAT) for many individuals with opioid use disorder, including poor and uninsured patients and those involved in the criminal justice (CJ) system. Substance use treatment services that are tailored to the unique needs of patients often produce better outcomes, but little national research has addressed characteristics associated with whether OTPs offer services specifically tailored to community members involved in the CJ system. Medicaid expansion under the Affordable Care Act has broadly strengthened MAT services, but the role of expansion in supporting MAT services that are specifically tailored towards CJ-involved populations remains unknown. Moreover, it is unknown whether the availability of tailored services varies between Medicaid expansion states.

Methods: We used the 2019 National Survey of Substance Abuse Treatment Services to identify OTPs in the US (n = 1679) and whether they offered services specifically tailored for CJ-involved patients. We used logistic regression to model the association between OTPs offering tailored services and state Medicaid expansion status, adjusted for state-level opioid overdose and community supervision rates.

Results: Nationally, only a quarter of OTPs offered services tailored to CJ populations, and the majority of OTPs (73%) were located in Medicaid expansion states. Compared to OTPs in non-expansion states, OTPs in expansion states demonstrated nearly double the odds of offering tailored services (adjusted odds ratio = 1.90, 95% confidence interval = 1.41-2.57, p < 0.0001). The predicted probability of offering tailored services varied by state; probability estimates for all expansion states were above the national mean, and estimates for all non-expansion states were below the national mean.

Conclusion: Our findings reiterate the role of Medicaid in promoting the adoption of comprehensive OTP services for CJ-involved populations. However, the proportion of OTPs that offered tailored services was relatively low, pointing to the need to continually strengthen Medicaid services and coverage.

Keywords: Criminal justice; Epidemiology; Opioid treatment programs; Opioid use disorder.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Predicted probability of OTPs offering services specifically tailored to criminal justice-involved patients, by state and Medicaid expansion status (N-SSATS; 2019; n = 1679 OTPs). Note: National predicted probability = 0.26
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. O'Donnell J, Gladden R, Mattson C, Hunter C, Davis N. Vital signs: characteristics of drug overdose deaths involving opioids and stimulants - 24 states and the Disctrict of Columbia, January - June 2019. Morbidity Mortal Weekl Rep (MMWR) 2020;69(35):1189–1197. doi: 10.15585/mmwr.mm6935a1. - DOI - PMC - PubMed
    1. American Medical Association. Issue Brief: Reports of increases in opioid- and other drug-related overdose and other concerns during COVID pandemic. American Medical Association Advocacy Resource Center. Updated December 9, 2020. 2020
    1. Bell J, Strang J. Medication treatment of opioid use disorder. Biol Psychiatry. 2020;87(1):82–88. doi: 10.1016/j.biopsych.2019.06.020. - DOI - PubMed
    1. Jones C, Campopiano M, Baldwin G, McCance-Katz E. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health. 2015;105(8):e55–e63. doi: 10.2105/AJPH.2015.302664. - DOI - PMC - PubMed
    1. Alderks C. Trends in the use of methadone, buprenorphine, and extended-release naltrexone at substance abuse treatment facilities: 2003–2015 (update) Rockville: Center for Behavioral Health Statistics and Quality, Substance Abuse and Mental Health Services Administration; 2017. - PubMed

Substances